MedTrace Logo

Retrospective Analysis of Ialuril vs. Standard of Care in Recurrent Urinary Tract Infections

NCT02016118 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2014-02-12

No results posted yet for this study

Summary

The purpose of this study is to assess the effectiveness and costs associated with the intravesical administration of combined hyaluronic acid (HA) and chondroitin sulphate (CS) compared to the current standard management of recurrent urinary tract infections in adult women diagnosed with recurrent urinary tract infections (RUTI).

Conditions

  • Recurrent Urinary Tract Infections

Interventions

DEVICE

Ialuril

The treatment is an intravesical administration of combined hyaluronic acid (HA) 1.6% and chondroitin sulphate (CS) 2.0% once per week for the first month, followed by one instillation every two weeks for the second month and one instillation per month until stable remission of the symptoms.

Sponsors & Collaborators

  • Study Group for Urogenital Diseases, Italy

    lead OTHER

Principal Investigators

  • Massimo Lazzeri, PhD · Università Vita-Salute San Raffaele

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-01-31
Primary Completion
2014-03-31
Completion
2014-12-31

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02016118 on ClinicalTrials.gov